Kyungdong Pharm operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kyungdong Pharm with three other
companies in this sector in KOREA (SOUTH) :
Kolon Life Science Incorporation
sales of 148.54 billion Korean Won [US$126.26 million]
of which 98%
Kyongbo Pharmaceutical Co Ltd
(191.71 billion Korean Won [US$162.95 million]
of which 37%
was General API), and
(168.76 billion Korean Won [US$143.45 million]
During the year ended December of 2019, sales at
Kyungdong Pharm were 176.50 billion Korean Won (US$150.03 million).
decrease of 1.6%
versus 2018, when the company's sales were 179.32 billion Korean Won .
Contributing to the drop in overall sales was the 38.1% decline
in Other Segment, from 14.08 billion Korean Won to 8.71 billion Korean Won .
There were also decreases in sales in
Rental (down 8.5% to 2.50 billion Korean Won )
However, these declines were partially offset by the increase in sales of
Medicine (up 0.6% to 167.76 billion Korean Won )